Bioprosthetic Valve Fracture 3 Years Post-Valve-in-Valve TAVR.

JACC Cardiovasc Interv

Centre for Cardiovascular Innovation, St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada; Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, British Columbia, Canada; Cardiovascular Translational Laboratory, Providence Research & Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada. Electronic address:

Published: September 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2023.07.014DOI Listing

Publication Analysis

Top Keywords

bioprosthetic valve
4
valve fracture
4
fracture years
4
years post-valve-in-valve
4
post-valve-in-valve tavr
4
bioprosthetic
1
fracture
1
years
1
post-valve-in-valve
1
tavr
1

Similar Publications

Background: Since the transcatheter valve-in-valve (ViV) procedure was introduced in 2007, a few cases of infective endocarditis (IE) following the ViV procedure have been reported, which can be predisposed by older age, pre-existing medical conditions, and procedural techniques. Paravalvular abscesses constitute a rare complication of IE, resulting from extending IE beyond the valve annulus, less commonly caused by species. This complication is more common in prosthetic valves, particularly bioprosthetic valves.

View Article and Find Full Text PDF

Background: Transcatheter valve-in-valve replacement (TMViVR) is an alternative option for patients with bioprosthetic valve failure (BVF) who are at high surgical risk. Although infective endocarditis (IE) after transcatheter mitral valve-in-valve replacement is unusual, it is associated with significantly high mortality.

Case Presentation: An 81-year-old male patient was admitted with intermittent thoracic tightness, chest pain persisting for 3 years, and shortness of breath with nausea for 1 week.

View Article and Find Full Text PDF

Background: Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is associated with improved perioperative safety compared to redo surgical aortic valve replacement (redo-SAVR), but long-term outcomes remain uncertain. We therefore compare long-term outcomes of ViV-TAVR and redo-SAVR.

Methods: The study included 1:1 propensity-matched Medicare beneficiaries with degenerated bioprosthetic valves admitted between 09/29/2011 and 12/30/2020 undergoing either redo-SAVR or ViV-TAVR.

View Article and Find Full Text PDF

The low durability of bioprosthetic heart valves (BHV), between 10-15 years, is associated with the development of leaflets flutter. Despite increasing calcification and structural damage of the BHV, leaflets flutter is an understudied condition. Therefore, the objective of this study is compare the oscillation characteristics of BHV leaflets obtained by the finite element method (FEM) technique and by the fluid-structural interaction (FSI) technique.

View Article and Find Full Text PDF

The Ross procedure continues to be the best procedure to address unrepairable aortic valve pathology, especially in young adults. The Achilles heel of this procedure has been aortic root dilation and the potential need for a reoperation that may be associated with slightly increased risks in addition to the need for intervention on the pulmonary outflow tract. Modifying the Ross procedure by autograft inclusion inside a Dacron graft seems to have the potential advantage of stabilizing the autograft diameter, which may be associated with improved durability and decrease the need for future intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!